Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
AstraZeneca
Pharma
AZ, Daiichi's Enhertu helps patients with brain metastases
Daiichi Sankyo and AstraZeneca are padding the case for Enhertu with new data showing the ADC's worth in patients whose cancer has reached the brain.
Fraiser Kansteiner
Sep 13, 2024 11:04am
AstraZeneca stands by Truqap despite surprise breast cancer flop
Sep 13, 2024 10:00am
Akeso-Summit, BIOSECURE, Candid and more—Fierce Pharma Asia
Sep 13, 2024 8:53am
Novartis, Daiichi, AZ shine in ESMO analysis of cancer approvals
Sep 13, 2024 8:06am
AZ loses $130M to Syntimmune shareholders in post-merger suit
Sep 9, 2024 11:43am
J&J builds case for Tagrisso rival with survival analysis
Sep 8, 2024 2:07pm
